NIP
RMD icon

Nicholas Investment Partners’s ResMed RMD Stock Holding History

Nicholas Investment Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,837
Closed -$315K – 186
2020
Q3 		$315K Buy
+1,837
New +$339K 0.03% 164

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nicholas Investment Partners's RMD Position: Q4 2020 in Review

Nicholas Investment Partners sold out of ResMed (RMD) in Q4 2020, closing a stake of 1,837 shares — an estimated $315K sold.

Nicholas Investment Partners first reported a position in RMD in Q3 2020 and held it in 1 quarter. The position peaked at $315K in Q3 2020. 663 funds tracked by Wall St. Rank hold RMD as of Q4 2020.

  • Nicholas Investment Partners reported no remaining ResMed position as of Q4 2020 after selling out during the quarter.
  • Nicholas Investment Partners sold 1,837 ResMed shares in Q4 2020, an estimated $315K.
  • Nicholas Investment Partners first reported a position in ResMed in Q3 2020 and held it in 1 quarter.
  • Nicholas Investment Partners's ResMed position peaked at $315K in Q3 2020.
  • 663 funds tracked by Wall St. Rank held ResMed as of Q4 2020.

Based on Nicholas Investment Partners's 13F filing for Q4 2020, filed 11 Feb 2021.